Gary S. Figiel | Psychiatrist.com

Original Research

Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil: An Open-Label Extension Study

October 15, 2008

Gary S. Figiel, Barbara Koumaras, Xiangyi Meng, et al

Original Research

Safety and Efficacy of Rivastigmine in Patients With Alzheimer's Disease Not Responding Adequately to Donepezil: An Open-Label Study

August 15, 2008

Gary S. Figiel, Carl H. Sadowsky, John Strigas, et al